How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Author Information
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Lab scientists using testing equipment too quickly brings up training concerns in discussions at recent ADLM conference
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Cybersecurity expert explains the importance of such assessments, which simulate malicious attacks to identify IT vulnerabilities.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
This checklist can help labs monitor their organization’s business arrangements that concern digital pathology to ensure compliance.